LAMP2a is Essential for the Bioactivity of Aripiprazole in the RNH1/miR‐99a/mTOR Regulatory Axis and Serves as a Favorable Prognostic Biomarker in CRC. This evidence concerns the gene RNH1 and colorectal carcinoma.